FFNTF - 4Front Ventures Corp.
0
0 0%
Share volume: 1,875
Last Updated: 03-17-2026
Pharmaceutical Products/Medicinal Chemicals:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$0.00
0.00
0.00%
View ratios
| Fiscal Date | 09-30-2024 | |
|---|---|---|
| Fiscal Quarter | Q3 2024 | |
| Report Date | 11-14-2024 | |
| Total revenue | 17.132 M | |
| Cost of revenue | 13.468 M | |
| Gross profit | 3.664 M | |
| Operating expenses | 9.919 M | |
| Selling general and admin | 9.919 M | |
| Research and development | 0.000 | |
| Total expenses | 9.031 M | |
| Operating income | -5.367 M | |
| Ebit | -2.984 M | |
| Pretax income | -6.463 M | |
| Income tax | 0.000 | |
| Net income basic | 0.000 | |
| Net income | -6.403 M | |